Humana Inc. $HUM Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lessened its position in shares of Humana Inc. (NYSE:HUM) by 16.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 63,495 shares of the insurance provider’s stock after selling 12,093 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Humana were worth $11,009,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in HUM. Montag A & Associates Inc. increased its stake in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the last quarter. CoreCap Advisors LLC lifted its stake in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana during the 4th quarter worth $27,000. Reflection Asset Management acquired a new stake in shares of Humana during the 4th quarter worth about $29,000. Finally, Larson Financial Group LLC raised its holdings in Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have commented on HUM. JPMorgan Chase & Co. upped their target price on shares of Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a research report on Monday, June 8th. Mizuho boosted their price target on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Royal Bank Of Canada upped their price objective on shares of Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. UBS Group assumed coverage on shares of Humana in a research report on Thursday. They set a “buy” rating for the company. Finally, Wells Fargo & Company upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $227.00 to $502.00 in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, thirteen have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average target price of $386.61.

Humana Stock Performance

Shares of HUM opened at $374.27 on Tuesday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The stock has a market capitalization of $44.94 billion, a PE ratio of 35.41, a PEG ratio of 2.08 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a 50-day simple moving average of $372.12 and a 200-day simple moving average of $269.02.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.27 earnings per share. On average, analysts predict that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.